Davidson Kempner Capital Management’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

Davidson Kempner Capital Management’s Portfolio IQMD Stock Details IQMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-100,000	Closed	-$1.03M	–	444
2022 Q4	$1.03M	Hold	100,000	–	–	0.02%	266
2022 Q3	$1.01M	Hold	100,000	–	–	0.02%	315
2022 Q2	$999K	Hold	100,000	–	–	0.02%	325
2022 Q1	$999K	Buy	+100,000	New	+$993K	0.01%	359

Other funds holding IQMD

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

Davidson Kempner Capital Management's IQMD Position: Q1 2023 in Review

Davidson Kempner Capital Management sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q1 2023, closing a stake of 100,000 shares — an estimated $1.03M sold.

Davidson Kempner Capital Management first reported a position in IQMD in Q1 2022 and held it in 4 quarters. The position peaked at $1.03M in Q4 2022. 8 funds tracked by Wall St. Rank hold IQMD as of Q1 2023.

Davidson Kempner Capital Management reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
Davidson Kempner Capital Management sold 100,000 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q1 2023, an estimated $1.03M.
Davidson Kempner Capital Management first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 4 quarters.
Davidson Kempner Capital Management's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $1.03M in Q4 2022.
8 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q1 2023.

Based on Davidson Kempner Capital Management's 13F filing for Q1 2023, filed 15 May 2023.